These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2874651)

  • 21. Widespread occurrence of AP in amyloidotic tissues. An immunohistochemical observation.
    Shirahama T; Skinner M; Sipe JD; Cohen AS
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 48(3):197-206. PubMed ID: 2859693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of ubiquitin to experimentally induced murine AA amyloid.
    Chronopoulos S; Alizadeh-Khiavi K; Normand J; Ali-Khan Z
    J Pathol; 1991 Mar; 163(3):199-203. PubMed ID: 1707449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
    Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
    Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraperitoneal amyloid formation by amyloid enhancing factor--rich macrophages in ascitic fluid.
    Miura K; Baba S; Shirasawa H; Ju ST; Cohen AS; Shirahama T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(4):245-50. PubMed ID: 1359697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum amyloid A gene expression and AA amyloid formation in A/J and SJL/J mice.
    Rokita H; Shirahama T; Cohen AS; Sipe JD
    Br J Exp Pathol; 1989 Jun; 70(3):327-35. PubMed ID: 2765389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid enhancing factor in hamster.
    Hol PR; van Andel AC; van Ederen AM; Draaÿer J; Gruys E
    Br J Exp Pathol; 1985 Dec; 66(6):689-97. PubMed ID: 4084449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alveolar hydatid cyst induced amyloid enhancing factor (AEF): physicochemical properties and abolition of AEF activity by serine protease inhibitors.
    Abankwa GV; Ali-Khan Z
    Br J Exp Pathol; 1988 Feb; 69(1):133-48. PubMed ID: 3162377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceleration of murine AA amyloid deposition by bovine amyloid fibrils and tissue homogenates.
    Cui D; Kawano H; Hoshii Y; Liu Y; Ishihara T
    Amyloid; 2008 Jun; 15(2):77-83. PubMed ID: 18484333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusible amyloid oligomers trigger systemic amyloidosis in mice.
    Senthilkumar S; Chang E; Jayakumar R
    Biochem J; 2008 Oct; 415(2):207-15. PubMed ID: 18564059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceleration of murine AA amyloidosis by oral administration of amyloid fibrils extracted from different species.
    Cui D; Kawano H; Takahashi M; Hoshii Y; Setoguchi M; Gondo T; Ishihara T
    Pathol Int; 2002 Jan; 52(1):40-5. PubMed ID: 11940205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Murine alveolar hydatidosis: a potential experimental model for the study of AA-amyloidosis.
    Ali-Khan Z; Jothy S; Al-Karmi T
    Br J Exp Pathol; 1983 Dec; 64(6):599-611. PubMed ID: 6661394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further characterization of amyloid-enhancing factor.
    Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
    Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmissibility of systemic amyloidosis by a prion-like mechanism.
    Lundmark K; Westermark GT; Nyström S; Murphy CL; Solomon A; Westermark P
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6979-84. PubMed ID: 12011456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid membranes accelerate amyloid formation in the mouse model of AA amyloidosis.
    Vahdat Shariat Panahi A; Hultman P; Öllinger K; Westermark GT; Lundmark K
    Amyloid; 2019 Mar; 26(1):34-44. PubMed ID: 30929476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice.
    Ganowiak K; Hultman P; Engström U; Gustavsson A; Westermark P
    Biochem Biophys Res Commun; 1994 Feb; 199(1):306-12. PubMed ID: 8123028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerated resolution of AA amyloid in heparanase knockout mice is associated with matrix metalloproteases.
    Wang B; Tan YX; Jia J; Digre A; Zhang X; Vlodavsky I; Li JP
    PLoS One; 2012; 7(7):e39899. PubMed ID: 22808071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
    Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
    Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic mice.
    Kennel SJ; Macy S; Wooliver C; Huang Y; Richey T; Heidel E; Wall JS
    Amyloid; 2014 Mar; 21(1):45-53. PubMed ID: 24446872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depletion of spleen macrophages delays AA amyloid development: a study performed in the rapid mouse model of AA amyloidosis.
    Lundmark K; Vahdat Shariatpanahi A; Westermark GT
    PLoS One; 2013; 8(11):e79104. PubMed ID: 24236094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.